SALITRACK PHARMA ApS
CVR 44952068 · Private limited company (ApS) · Active · High risk
SALITRACK PHARMA ApS is a Private limited company (ApS), founded on , based in Rødovre. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 3.4% over the next 12 months, which is 2.4 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 11k and a net result of DKK -29k. CEO: Balwant Rai.
Bankruptcy risk for SALITRACK PHARMA ApS
2.4 × the average (1.41%) · higher risk than 88% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44952068
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- Agerskovvej 1A, 1. tv
2610 Rødovre - Municipality
- Rødovre
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 40k
- Auditor
- Redmark, Godkendt Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 7.9% |
| Current ratio | 109% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK -29k |
| Net profit | DKK -29k |
| Equity | DKK 11k |
| Total assets | DKK 134k |
| Cash | DKK 134k |
| Short-term debt | DKK 123k |
| Avg. employees | 0 |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Redmark, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 4 Jul 2024 – 31 Dec 2025 | 166 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Balwant Rai | Current | |
| Owner (100%) | Balwant Rai | Current | |
| Founder | Balwant Rai | Current |
Address history (0 moves)
| Agerskovvej 1A, 1. tv, 2610 Rødovre |
Questions and answers about SALITRACK PHARMA ApS
Has SALITRACK PHARMA ApS gone bankrupt?
No, SALITRACK PHARMA ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of SALITRACK PHARMA ApS?
Our model estimates a bankruptcy risk of 3.4% over the next 12 months (high risk), which is 2.4 times the average for Danish companies.
Who is the CEO of SALITRACK PHARMA ApS?
Balwant Rai is the CEO of SALITRACK PHARMA ApS.
Who is the auditor of SALITRACK PHARMA ApS?
SALITRACK PHARMA ApS most recently used Redmark, Godkendt Revisionspartnerselskab.
When was SALITRACK PHARMA ApS founded?
SALITRACK PHARMA ApS was founded on 4 July 2024.
What is the equity of SALITRACK PHARMA ApS?
Equity was DKK 11k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.